|
Hi! As newsrooms face continued pressure from layoffs, shrinking budgets, and evolving business models, many respected healthcare and biopharma journalists are leaving traditional media organizations to build independent, subscriber-supported platforms. At T2B's Q2 Media Minds Roundtable event later this month, we'll hear from a group of journalists who have made that transition, and explore the implications for communicators, the media ecosystem, and our industry at large. From Newsroom to Newsletter: Why Healthcare's Top Journalists Are Going Independent📅 Thursday, June 25th @ 11 a.m.-12 p.m. ET / 8-9 a.m. PT / 4-5 p.m. BST Featuring:
We'll discuss:
Since independent journalism is becoming a significant part of the healthcare media ecosystem, I'm eager to hear how our panelists are navigating their ventures and their thoughts on what it means for all of us! Lynnea |
Hi! Just a few minutes ago at our Biopharma Comms Forum, T2B's AI Roundtable with Knowledge Partner Syneos Health Communications shared the findings of our inaugural AI in Biopharma Communications Survey. The biggest takeaway: While many of us are regularly using AI in our work, there's a huge lag in the tools, training, governance, measurement, and expectations needed to support that use confidently, responsibly, and sustainably. We invite you to peruse the full Survey Executive Summary. The...
Hi! Michelle and I are here in Boston, and we can’t wait to see you all tomorrow for our second annual Biopharma Comms Forum, Clarity at the Flashpoint, at The Alumni Center at our alma mater, Northeastern University. We have a full day of panels, keynotes, and conversations planned, all designed to address the key issues we communications leaders are facing, including ways to: Navigate uncertainty when there isn't a standard how-to. Build influence that extends beyond reporting lines and org...
Hi! During T2B's recent, inaugural Digital & Social Media Roundtable event, "How Influencers, Social, and Forums Are Shaping AI Search Results," we explored why social platforms, community conversations, earned media, and influencer content are becoming increasingly important inputs into the information people see, and what this shift means for us biopharma communicators. Here are our top 10 takeaways: T2B Pro members can also flip through the presentation slides and watch the replay here. 1....